Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-068005
Filing Date
2025-05-09
Accepted
2025-05-09 16:05:39
Documents
54
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q maia-20250331.htm   iXBRL 10-Q 1593518
2 EX-31.1 maia-ex31_1.htm EX-31.1 17997
3 EX-31.2 maia-ex31_2.htm EX-31.2 19274
4 EX-32.1 maia-ex32_1.htm EX-32.1 10525
5 EX-32.2 maia-ex32_2.htm EX-32.2 11788
  Complete submission text file 0000950170-25-068005.txt   6842288

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT maia-20250331.xsd EX-101.SCH 953372
56 EXTRACTED XBRL INSTANCE DOCUMENT maia-20250331_htm.xml XML 1120866
Mailing Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606
Business Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606 312-416-8592
MAIA Biotechnology, Inc. (Filer) CIK: 0001878313 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41455 | Film No.: 25930353
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)